Dasatinib

Also known as: Sprycel, BMS-354825

Dasatinib is a pharmaceutical drug primarily used in the treatment of certain types of leukemia, such as chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It is classified as a tyrosine kinase inhibitor, which means it works by blocking specific enzymes known as tyrosine kinases. These enzymes are responsible for the growth and proliferation of cancer cells. By inhibiting these enzymes, Dasatinib effectively slows down or stops the progression of cancer, helping to manage the disease and improve patient outcomes. Developed by Bristol-Myers Squibb and first approved by the...

Potential Side Effects

Side effects score: 7; Dasatinib is a medication primarily used to treat certain types of leukemia, and like many medications, it can have side effects. Common side effects include low blood cell counts, which can increase the risk of infections, bleeding, and fatigue. Some people may experience fluid retention, leading to swelling in the hands, feet, or around the lungs. Other possible side effec